ImmunoGrid

The project will focus on establishing an infrastructure for the simulation of the immune system that integrates processes at molecular, cellular, and organ levels. It will be designed for applications that support clinical outcomes such as design of vaccines and immunotherapies and optimization of immunization protocols.

The immune system is a complex and adaptive learning system which has evolved to defend the individual. It has multiple levels (molecular, cellular, organ and tissue, organism, and organism-toorganism) and is also combinatorial in nature with a large number of products.

Immune intervention, such as vaccination, is the most effective method for the control of disease and the greatest achievements include eradication of smallpox, near-elimination of polio, and savings of some 170 million person-years. Vaccination has been used in the control of over two dozen diseases by the 50 or so successful vaccines which have been developed to date.

Large-scale studies of the immune system, also known as immunomics, is the key factor driving the current wave in vaccine development. The main objectives of ImmunoGrid are to:

  • Create computational models for the real-size human immune system (the Virtual Human Immune System Simulator).
  • Standardize immune system concepts, bioinformatics tools and information resources to enhance the computational models for preclinical and clinical applications.
  • Validate these models with experimental data and disseminate the tools developed to users such as vaccine and immunotherapy researchers and developers.

For further information, please visit:

Project co-ordinator:
The Interuniversity Consortium of Northeastern Italy for Automated Computing (CINECA) (IT)

Partners:

  • National Council of Research - CNR (IT),
  • National Council of Scientific Research - CNRS (FR),
  • University of Queensland (AU),
  • Technical University of Denmark (DK),
  • Birkbeck College, Univ. of London (UK),
  • University of Bologna (IT),
  • University of Catania (IT)

Timetable: from 02/06 – to 01/09

Total cost: € 2.622.274

EC funding: € 1,951,042

Instrument: STREP

Project Identifier: IST-2004-028069

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...